BioAtrium AG
BioAtrium AG, headquartered in Switzerland (CH), is a pioneering company in the biotechnology sector, specialising in innovative solutions for the life sciences industry. Founded in 2015, BioAtrium has rapidly established itself as a leader in the development of advanced biopharmaceuticals and diagnostic tools, focusing on enhancing patient outcomes through cutting-edge research and technology. With a strong presence in Europe and expanding operations globally, BioAtrium AG offers a unique portfolio of products and services, including bespoke bioprocessing solutions and state-of-the-art analytical services. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner for pharmaceutical and biotech companies. Notable achievements include successful collaborations with leading research institutions, underscoring BioAtrium's role in advancing the field of biotechnology.
DitchCarbon Score
How does BioAtrium AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioAtrium AG's score of 6 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BioAtrium AG's reported carbon emissions
BioAtrium AG, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that BioAtrium AG has not outlined any specific reduction targets or commitments to climate initiatives. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, BioAtrium AG's future commitments and actions will be crucial in aligning with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BioAtrium AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
